Results 11 to 20 of about 6,033 (210)

Pleiotrophin Interaction with Synthetic Glycosaminoglycan Mimetics

open access: yesPharmaceuticals, 2022
Chondroitin sulfate (CS) E is the natural ligand for pleiotrophin (PTN) in the central nervous system (CNS) of the embryo. Some structures of PTN in solution have been solved, but no precise location of the binding site has been reported yet.
Jonathan R. Miles   +3 more
doaj   +4 more sources

Pleiotrophin Expression and Actions in Pancreatic β-Cells [PDF]

open access: yesFrontiers in Endocrinology, 2022
Pleiotrophin (PTN) is a heparin-binding cytokine that is widely expressed during early development and increases in maternal circulation during pregnancy.Aged PTN-deficient mice exhibit insulin resistance, suggesting a role in metabolic control.
Julio Sevillano   +11 more
doaj   +3 more sources

Increased Pleiotrophin Concentrations in Papillary Thyroid Cancer. [PDF]

open access: yesPLoS ONE, 2016
BACKGROUND:Thyroid nodules are common, and approximately 5% of these nodules are malignant. Pleiotrophin (PTN) is a heparin-binding growth factor which is overexpressed in many cancers.
Youn Hee Jee   +9 more
doaj   +4 more sources

Behavioral and neuroanatomical abnormalities in pleiotrophin knockout mice. [PDF]

open access: yesPLoS ONE, 2014
Pleiotrophin (PTN) is an extracellular matrix-associated protein with neurotrophic and neuroprotective effects that is involved in a variety of neurodevelopmental processes.
Jason W Krellman   +4 more
doaj   +3 more sources

Targeting the PTN/PTPRZ1-ROS Pathway to Promote Bone Regeneration [PDF]

open access: yesBiomedicines
Background: Osteoporosis is a global health problem that significantly decreases patients’ quality of life and causes tremendous medical burdens. Therefore, exploring effective targeting strategies for osteoporosis treatment is crucial.
Kai Zhao   +6 more
doaj   +2 more sources

Beyond Amyloid: Targeting Co-Aggregating Proteins and Targeted Degradation Strategies in Alzheimer’s Disease [PDF]

open access: yesBiomedicines
Alzheimer’s disease (AD) involves a constellation of molecular processes that extend well beyond amyloid-β (Aβ) accumulation. Recent anti-amyloid antibodies provide limited clinical benefits, highlighting the need for additional strategies due to their ...
Martina Monaco   +2 more
doaj   +2 more sources

miR-338-3p promotes radiation recall like dermatitis by suppressing pleiotrophin via the PI3K/Akt/Bcl2 pathway [PDF]

open access: yesMolecular Biomedicine
Radiation recall dermatitis (RRD) is a rare but severe inflammatory reaction induced by certain drugs in previously irradiated skin, which can markedly impair quality of life and disrupt cancer treatment.
Yu Min   +7 more
doaj   +2 more sources

The effects of pleiotrophin in proliferative diabetic retinopathy. [PDF]

open access: yesPLoS ONE, 2015
Pleiotrophin (PTN), a secreted, multifunctional cytokine, is involved in angiogenic, fibrotic and neurodegenerative diseases. However, little is known about its effects on diabetic retinopathy, a neurovascular disease.
Xuemei Zhu   +11 more
doaj   +4 more sources

Inflammatory Mediators Both Directly and Indirectly Promote Microglial Proliferation. [PDF]

open access: yesGlia
– CSF2, IL3, and TNFɑ directly promote microglial proliferation. – Neuron‐secreted factors suppress microglial proliferation. – IL1 cytokines promote CSF2 release from astrocytes, which promotes microglial proliferation. ABSTRACT Microglia—the predominant immune cell of the central nervous system (CNS)—possess an astounding capacity for proliferation ...
Hammond BP   +4 more
europepmc   +2 more sources

Pleiotrophin/Midkine Pathway Is Dysregulated in a TDP-43A315T Mouse Model of Amyotrophic Lateral Sclerosis (ALS). [PDF]

open access: yesNeuropathology
ABSTRACT Amyotrophic lateral sclerosis (ALS) is a fatal motor neuron disease (MND) characterized by progressive degeneration of both upper and lower motor neurons, along with skeletal muscles innervated by them. The identification of key molecules involved in disease pathology remains crucial for ALS, as no curative treatment is currently available ...
Martínez-Alesón P   +3 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy